4 withdrawn. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers Lutetium Lu 177 Dotatate - Locally Advanced Adrenal Gland Pheochromocytoma, Locally Advanced Paraganglioma | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2019-06-13 | 2020-09-07 | |
| Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) Lunacalcipol 180, Lunicalcipol 270 - Stage 5 Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism (SHPT) | Phase 2 | Withdrawn | OPKO Health, Inc. | 2013-01-01 | 2014-09-22 | |
| Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy Yougui granules, Zuogui granules, Yougui granules placebo - Renal Insufficiency, Chronic, Renal Osteodystrophy | Phase 2 | Withdrawn | Bing Shu | 2012-08-01 | 2017-05-08 | |
| Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D Placebo, Vitamin D3 - Primary Hyperparathyroidism, Hypercalcemia | Phase 2 / Phase 3 | Withdrawn | Columbia University | 2010-05-01 | 2015-03-05 |
Renal Insufficiency, Chronic (2) · Bone Diseases, Metabolic (1) · Carcinoma, Medullary (1) · Chronic Kidney Disease-Mineral and Bone Disorder (1) · Hypercalcemia (1) · Hyperparathyroidism, Primary (1) · Hyperparathyroidism, Secondary (1) · Osteoporosis (1) · Paraganglioma (1) · Parathyroid Neoplasms (1) · Pheochromocytoma (1) · Pituitary Neoplasms (1) · Vitamin D Deficiency (1)
Endocrine System Diseases (4) · Hyperparathyroidism (3) · Avitaminosis (2) · Bone Diseases (2) · Calcium Metabolism Disorders (2) · Chronic Disease (2) · Deficiency Diseases (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Malnutrition (2) · Metabolic Diseases (2)
Cholecalciferol (1) · lutetium Lu 177 dotatate (1)
Bing Shu (1) · Columbia University (1) · M.D. Anderson Cancer Center (1) · OPKO Health, Inc. (1)
United States (2) · China (1)
Camilo Jimenez (1) · Shonni J. Silverberg, MD (1) · Yongjun Wang, Doctor (1)
R01DK084986 (1)